Literature DB >> 394737

High-dose methotrexate therapy--an area of uncertainty.

J W Paxton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 394737     DOI： 10.1111/j.1445-5994.1979.tb04209.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN： 0004-8291


× No keyword cloud information.
  7 in total

1.  A microbiological assay for the measurement of methotrexate in biological fluids.

Authors:  G C Icke; R E Davis; J Thom
Journal:  J Clin Pathol       Date:  1983-10       Impact factor: 3.411

2.  Cephalosporins increase the renal clearance of methotrexate and 7-hydroxymethotrexate in rabbits.

Authors:  H Iven; H Brasch
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  The effects of antibiotics and uricosuric drugs on the renal elimination of methotrexate and 7-hydroxymethotrexate in rabbits.

Authors:  H Iven; H Brasch
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

4.  Serum profiles and safety of intermediate-dose (500-1,000 mg) methotrexate following IV and IM administration.

Authors:  B M Colls; R A Robson; B A Robinson; G W Tisch
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

5.  Clearance studies of methotrexate and 7-hydroxy-methotrexate in rabbits after multiple-dose infusion.

Authors:  M L Chen; W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1983-10

6.  Pharmacokinetics of methotrexate (MTX) and 7-hydroxymethotrexate (7-OH-MTX) in rats and evidence for the metabolism of MTX to 7-OH-MTX.

Authors:  L Fahrig; H Brasch; H Iven
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 7.  Antineoplastic agents. Drug interactions of clinical significance.

Authors:  E van Meerten; J Verweij; J H Schellens
Journal:  Drug Saf       Date:  1995-03       Impact factor: 5.606
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.